The drug war: why drugs are expensive and how the fight for access is losing momentum
In an increasingly globalised world, the drug war has become a huge business.
In an age of cheap global supply chains and a growing global demand for generic medicines, it has become even bigger.
It’s a battle of the drugs.
The stakes are high.
In the last few years, the cost of pharmaceuticals has exploded from $1.5 billion in 2009 to more than $1 trillion in 2016.
A global shortage of medicines and pharmaceuticals shortages are the main reasons why global pharmaceutical prices have soared from a peak of $2,000 per prescription in 2009, to more like $1,000 today.
In 2016, the World Health Organisation said that over half of all global medicines were in short supply, with over 40 per cent of the world’s population suffering from severe acute malnutrition.
This year, global supply-chain costs rose by more than 60 per cent, as the world was forced to buy more pharmaceuticals and pharmaceutical products than ever before.
So why is this happening?
The drugs that are the focus of the drug wars are very different to the drugs that we are used to getting.
The first drug to enter the global supply chain was called Ritalin, a stimulant and antidepressant, first introduced in 1955.
It was used to treat depression and narcolepsy in children and adults.
It gained popularity as a recreational drug, which led to its widespread use.
However, by the mid-1970s, it had become a powerful addictive drug.
It became a lot more dangerous and addictive than its manufacturer, Eli Lilly, had previously marketed it as.
Eli Lilly’s original formulation of Ritalins was called Vyvanse, and it was an improvement on the earlier Ritalinis, which were more powerful.
However by the early 1990s, the new formula was deemed to be more addictive and addictive-like than its predecessor.
The problem was, the people that were being prescribed it had been prescribed it for a long time.
The longer they were prescribed it, the more it became addictive.
As such, there was an increased demand for the drug, and therefore, more demand for Ritalinos, Ritalis and other drugs, which would make people addicted.
By the late 1980s, when Ritalino was taken off the market, people were starting to take the drug for medical reasons, and the drugs were getting harder to access.
This was a problem because if people started taking the drug and it became harder to get the drug off their shelves, they were more likely to die of an overdose or a fatal overdose.
In addition, as more people were taking Ritaloins, more and more people started developing the drug-resistant version, which was harder to take and more difficult to kill.
This resulted in more deaths, and more drugs being prescribed.
There were two problems with this: firstly, this meant that people would start taking Rita, Ritavac and other newer, stronger drugs that were much harder to obtain.
People also started using Ritalics more frequently because they were able to get them at pharmacies and online.
It also meant that more people died of an accidental overdose.
The other problem was that people were dying because they used drugs that they did not need.
For example, if someone took Ritalos to relieve anxiety, but later became suicidal, the Ritalian would not be able to make them better.
The drugs became increasingly hard to access, and so the drugs became more expensive, which meant people started using the drugs less frequently, because they could no longer afford to take them.
This led to more deaths.
The main reason for the drugs becoming harder to find was because they did more harm than good.
They made people think that they were not capable of being happy, that they could not be a productive member of society.
They led to people becoming depressed, and they led to a rise in drug-related hospitalisations, including suicides.
This is why the price of the new Ritalios is rising, as it is the same as the Ritavan, but the drugs are much more expensive.
There is a third reason for increasing the cost: the drugs can’t be manufactured and are not easily available.
As a result, the price is higher because of the difficulty in manufacturing them.
It is also because of how expensive the drugs become in the long term.
If you take a look at the world supply chain for medicines, the most important drug is the generic version, the version that is the most affordable.
This has been the case for over 30 years, and even though generic versions of drugs are increasingly more expensive than their branded counterparts, the market for these drugs remains largely stable.
If a drug becomes more expensive in the short term, then more people will start to try it, which will result in higher levels of drug use and drug-induced deaths. In turn